Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 22:S0140-6736(20)31174-0.
doi: 10.1016/S0140-6736(20)31174-0. Online ahead of print.

Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?

Christian Funck-Brentano  1 , Joe-Elie Salem  2
Affiliations

Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?

Christian Funck-Brentano et al. Lancet. .

Retraction in

No abstract available

PubMed Disclaimer

References

    1. Mason JW. Antimicrobials and QT prolongation. J Antimicrob Chemother. 2017;72:1272–1274. - PubMed
    1. White NJ. Cardiotoxicity of antimalarial drugs. Lancet Infect Dis. 2007;7:549–558. - PubMed
    1. Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. Europace. 2014;16:101–108. - PubMed
    1. Vlachos K, Georgopoulos S, Efremidis M, Sideris A, Letsas KP. An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol. 2016;9:117–127. - PubMed
    1. Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 doi: 10.1016/S0140-6736(20)31180-6. published online May 22. - DOI - PMC - PubMed

Publication types